Searched for
SYMBIOTEC PHARMALAB
Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...- Lalithaa Jewellery Mart shares shine on debut, list at 32% premium over IPO priceLalithaa Jewellery Mart Share Price: Lalithaa Jewellery Mart made a remarkable entrance on Monday, entering the stock market with a strong ...
- IPO rush continues: 10 issues to raise over Rs 3,500 crore this weekThis week sees the launch of six mainboard IPOs and four from the SME sector, with total fundraising expected to surpass Rs 3,500 crore. Am...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- 20 IPOs on investors' radar next week. GMPs indicate up to 90% returnsA total of 20 IPOs are on investors’ radar next week, including fresh issues and upcoming listings across the mainboard and SME segments. S...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- SAEL Industries, Vishvaraj Environment, Symbiotec Pharmalab and 3 others get Sebi nod to launch IPOSecurities and Exchange Board of India approved IPOs of six companies, including Vishvaraj Environment and SAEL Industries. Firms span sect...
- Symbiotec Pharmalab plans IPO to boost specialty pharma marketSymbiotec Pharmalab, a leading API manufacturer, is planning an IPO. The company targets a valuation of about $1 billion. The IPO aims to r...
- Foreign Investment Promotion Board to consider 31 FDI proposals on FridayProposals of Tevapharm India Pvt, GMU Infosoft Pvt, U Infosoft Pvt Ltd, and Monsoon Capital LLC, US are also among these nine investment pl...
- Government to consider 31 FDI proposals on December 16The government will consider 31 foreign investment proposals, including that of Ratnakar Bank, Novartis Healthcare and HDFC Bank, on Decemb...
- FIPB clears Mylan's acquisition of Strides Arcolab subsidiary Agila SpecialitiesThe board also cleared 15 foreign direct investment (FDI) proposal worth Rs 2,000 crore, the finance minister said in a statement on Friday.
- Govt clears 15 FDI proposals worth Rs 2,000.5 croreThe Finance Ministry today said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore and recommended two FDI applicat...
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- Mylan Inc's over 5,000 crore FDI in pharma sector may get government nodMylan Inc's over Rs 5,000 crore foreign direct investment proposal and a host of others in the pharmaceutical sector could soon see green l...
- Actis to buy 25% in steroids maker Symbiotec Pharmalab for Rs 300 crorePrivate equity fund Actis is looking to purchase more than 25% stake in cortico steroids maker Symbiotec Pharmalab for around $50 million.
- Franklin Templeton PE invests Rs 45 cr in drug-maker Symbiotec PharmalabSymbiotec is engaged in research, development, manufacturing and marketing of research-based active pharmaceutical ingredients for corticos...
- Lupin picks up majority stake in SymbiotecAs part of its plan to expand in the steroids segment, pharmaceutical firm Lupin on Thursday said it has acquired a majority stake in Symbi...
- Lupin joins hands with SymbiotecLupin on Thursday said it has made an equity investment in Symbiotec Pharmalab, a company focused on steroids, for a majority stake, in a b...
Load More
